X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (57) 57
female (55) 55
index medicus (49) 49
oncology (35) 35
adult (34) 34
middle aged (32) 32
aged (28) 28
cancer (23) 23
prognosis (22) 22
pathology (21) 21
immunohistochemistry (19) 19
breast cancer (17) 17
breast neoplasms - pathology (16) 16
expression (16) 16
neoplasm staging (16) 16
obstetrics & gynecology (16) 16
survival (16) 16
tumors (16) 16
carcinoma (14) 14
medicine & public health (13) 13
aged, 80 and over (12) 12
biomarkers, tumor - metabolism (11) 11
neoplasm grading (10) 10
ovarian cancer (10) 10
ovarian neoplasms - pathology (10) 10
endometrial neoplasms - pathology (9) 9
ovarian neoplasms - genetics (9) 9
retrospective studies (9) 9
diagnosis (8) 8
endometrial cancer (8) 8
follow-up studies (8) 8
health aspects (8) 8
metastasis (8) 8
biomarkers, tumor - genetics (7) 7
bone marrow - pathology (7) 7
cells (7) 7
development and progression (7) 7
immunoenzyme techniques (7) 7
lymph nodes - pathology (7) 7
ovarian neoplasms - metabolism (7) 7
survival rate (7) 7
tissue array analysis (7) 7
analysis (6) 6
bone-marrow (6) 6
cancer research (6) 6
endometrial carcinoma (6) 6
endometriosis (6) 6
internal medicine (6) 6
metastases (6) 6
ovarian carcinoma (6) 6
prospective studies (6) 6
stem cells (6) 6
surgery (6) 6
women (6) 6
article (5) 5
breast neoplasms - metabolism (5) 5
carcinoma, intraductal, noninfiltrating - pathology (5) 5
carcinoma, ovarian epithelial (5) 5
cystadenocarcinoma, serous - genetics (5) 5
disseminated tumor cell (5) 5
endometrium (5) 5
gene amplification (5) 5
gene expression (5) 5
guidelines (5) 5
kaplan-meier estimate (5) 5
lymphatic metastasis (5) 5
mutation (5) 5
ovarian neoplasms - mortality (5) 5
proteins (5) 5
reproductive biology (5) 5
research article (5) 5
reverse transcriptase polymerase chain reaction (5) 5
soxb1 transcription factors - genetics (5) 5
soxb1 transcription factors - metabolism (5) 5
survival analysis (5) 5
therapy (5) 5
tumor (5) 5
adenocarcinoma (4) 4
animals (4) 4
apoptosis (4) 4
biomarkers (4) 4
bone marrow (4) 4
breast neoplasms - drug therapy (4) 4
carcinoma, ductal (4) 4
carcinoma, ductal, breast - pathology (4) 4
care and treatment (4) 4
chemotherapy (4) 4
classification (4) 4
cystadenocarcinoma, serous - metabolism (4) 4
cystadenocarcinoma, serous - pathology (4) 4
ductal carcinoma in situ (4) 4
endometrial neoplasms - metabolism (4) 4
estrogen-receptor (4) 4
gene expression regulation, neoplastic (4) 4
identification (4) 4
laparoscopy (4) 4
low-grade (4) 4
male (4) 4
management (4) 4
obstetrics and gynecology (4) 4
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2013, Volume 14, Issue 7, pp. 609 - 618
Journal Article
BMC Cancer, ISSN 1471-2407, 01/2011, Volume 11, Issue 1, pp. 42 - 42
Journal Article
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2019, Volume 37, Issue 15_suppl, pp. 566 - 566
Journal Article
Human Pathology, ISSN 0046-8177, 2011, Volume 42, Issue 8, pp. 1078 - 1088
Journal Article
Modern Pathology, ISSN 0893-3952, 07/2011, Volume 24, Issue 7, pp. 944 - 953
Journal Article
Journal Article
Nature Communications, ISSN 2041-1723, 09/2016, Volume 7, Issue 1, p. 12852
Dissecting cellular signalling requires the analysis of large number of proteins. The DigiWest approach we describe here transfers the western blot to a... 
QUANTIFICATION | MULTIDISCIPLINARY SCIENCES | IMMUNOAFFINITY ENRICHMENT | RESISTANCE | DYNAMICS | MICROARRAYS | INHIBITORS | PROTEINS | MASS-SPECTROMETRY | GENOME | PROTEOMICS
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 11/2017, Volume 114, Issue 46, pp. E9942 - E9951
Immunotherapies, particularly checkpoint inhibitors, have set off a revolution in cancer therapy by releasing the power of the immune system. However, only... 
Mesothelin | Mucin 16 | Immunotherapy | Immunopeptidome | Ovarian cancer | SURVIVAL | ovarian cancer | mucin 16 | MULTIDISCIPLINARY SCIENCES | IMMUNE PRIVILEGE | immunopeptidome | TUMOR | ANTIGENS | CANCER-IMMUNOTHERAPY | IDENTIFICATION | mesothelin | ADVANCED MELANOMA | immunotherapy | EXPRESSION | T-CELLS | Membrane Glycoproteins - analysis | Kallikreins - immunology | CA-125 Antigen - immunology | Galectin 1 - immunology | Membrane Glycoproteins - metabolism | Humans | Vaccination | Gene Expression Regulation, Neoplastic | Ovarian Neoplasms - pathology | Neoplasms, Glandular and Epithelial - metabolism | Indoleamine-Pyrrole 2,3,-Dioxygenase - immunology | Neoplasms, Glandular and Epithelial - immunology | Histocompatibility Antigens Class I - metabolism | Female | Histocompatibility Antigens Class II - metabolism | Ovarian Neoplasms - metabolism | Membrane Glycoproteins - immunology | HLA-DR Antigens - metabolism | Neoplasms, Glandular and Epithelial - pathology | GPI-Linked Proteins - immunology | Histocompatibility Antigens Class I - immunology | Membrane Proteins - immunology | Antigen Presentation - immunology | Membrane Glycoproteins - genetics | Histocompatibility Antigens Class II - immunology | Carcinoma, Ovarian Epithelial | Ligands | HLA-DR Antigens - immunology | Ovarian Neoplasms - immunology | Physiological aspects | Antigens | Peptides | Health aspects | Biological Sciences | PNAS Plus
Journal Article
European Journal of Nuclear Medicine and Molecular Imaging, ISSN 1619-7070, 08/2017, Volume 44, Issue 9, pp. 1511 - 1519
Journal Article
British Journal of Cancer, ISSN 0007-0920, 08/2018, Volume 119, Issue 4, pp. 480 - 486
BACKGROUND: The newly developed Proactive Molecular Risk Classifier for Endometrial Cancer (ProMisE) has consistently been shown to be prognostically... 
SURVIVAL | PATHWAYS | CELL-ADHESION MOLECULE | PREDICTOR | ONCOLOGY | GENE-EXPRESSION | GRADE | E-CADHERIN | PATHOLOGY | CANCER | Immunohistochemistry | Carcinoma | Risk groups | Correlation analysis | p53 Protein | Risk assessment | Health risks | Multivariate analysis | Survival | Subgroups | Endometrium | Tumors | Biomarkers | Endometrial cancer | Outcomes research | Risk factors | Molecular medicine
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 07/2018, Volume 24, Issue 14, pp. 3358 - 3365
Journal Article